EXCHANGE AGREEMENTExchange Agreement • July 3rd, 2023 • Jaguar Health, Inc. • Pharmaceutical preparations • Utah
This Exchange Agreement (this “Agreement”) is entered into as of June 28, 2023 (the “Effective Date”) by and between [_______________________] (“Lender”), and Jaguar Health, Inc., a Delaware corporation (“Borrower”). Capitalized terms used in this Agreement without definition shall have the meanings given to them in the Royalty Interest (as defined below).
FIRST AMENDMENT TO STANDSTILL AGREEMENTStandstill Agreement • July 3rd, 2023 • Jaguar Health, Inc. • Pharmaceutical preparations
This FIRST AMENDMENT (this “Amendment”) to the Standstill Agreement (as hereinafter defined) is made effective as of June 28, 2023 (the “Amendment Effective Date”) by and among Iliad Research and Trading, L.P., a Utah limited partnership, or its successors or assigns (“Iliad”), Uptown Capital, LLC, a Utah limited liability company (f/k/a Irving Park Capital, LLC), or its successors or assigns (“Uptown”), Streeterville Capital, LLC, a Utah limited liability company, or its successors or assigns (“Streeterville,” and together with Iliad and Uptown, “Investor”), Jaguar Health, Inc., a Delaware corporation (“Jaguar”), and Napo Pharmaceuticals, Inc., a Delaware corporation and subsidiary of Jaguar (“Napo,” and together with Jaguar, “Company”).
